Titre : Acétylcystéine

Acétylcystéine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Recovery of Function
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Acétylcystéine : Questions médicales les plus fréquentes", "headline": "Acétylcystéine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Acétylcystéine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-13", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Acétylcystéine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cystéine", "url": "https://questionsmedicales.fr/mesh/D003545", "about": { "@type": "MedicalCondition", "name": "Cystéine", "code": { "@type": "MedicalCode", "code": "D003545", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.166.230" } } }, "about": { "@type": "MedicalCondition", "name": "Acétylcystéine", "alternateName": "Acetylcysteine", "code": { "@type": "MedicalCode", "code": "D000111", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "David L Morris", "url": "https://questionsmedicales.fr/author/David%20L%20Morris", "affiliation": { "@type": "Organization", "name": "St George and Sutherland Clinical School, University of New South Wales Kogarah, Sydney, NSW, Australia." } }, { "@type": "Person", "name": "Sarah J Valle", "url": "https://questionsmedicales.fr/author/Sarah%20J%20Valle", "affiliation": { "@type": "Organization", "name": "Mucpharm Pty Ltd, Kogarah Sydney, NSW, Australia." } }, { "@type": "Person", "name": "Krishna Pillai", "url": "https://questionsmedicales.fr/author/Krishna%20Pillai", "affiliation": { "@type": "Organization", "name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia." } }, { "@type": "Person", "name": "Samina Badar", "url": "https://questionsmedicales.fr/author/Samina%20Badar", "affiliation": { "@type": "Organization", "name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia." } }, { "@type": "Person", "name": "Javed Akhter", "url": "https://questionsmedicales.fr/author/Javed%20Akhter", "affiliation": { "@type": "Organization", "name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Functional Recovery During Inpatient Rehabilitation in Children With Anoxic or Hypoxic Brain Injury.", "datePublished": "2023-02-08", "url": "https://questionsmedicales.fr/article/36758714", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.apmr.2023.01.018" } }, { "@type": "ScholarlyArticle", "name": "Impact of intravenous dexmedetomidine on postoperative gastrointestinal function recovery: an updated meta-analysis.", "datePublished": "2024-03-01", "url": "https://questionsmedicales.fr/article/38085848", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/JS9.0000000000000988" } }, { "@type": "ScholarlyArticle", "name": "Factors associated with failure of cardiopulmonary function recovery after lung cancer surgery.", "datePublished": "2023-08-29", "url": "https://questionsmedicales.fr/article/37642118", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/resp.14581" } }, { "@type": "ScholarlyArticle", "name": "Cross-validation of predictive models for functional recovery after post-stroke rehabilitation.", "datePublished": "2022-09-07", "url": "https://questionsmedicales.fr/article/36071452", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12984-022-01075-7" } }, { "@type": "ScholarlyArticle", "name": "Effects of Rehabilitation Robot Training on Physical Function, Functional Recovery, and Daily Living Activities in Patients with Sub-Acute Stroke.", "datePublished": "2024-05-15", "url": "https://questionsmedicales.fr/article/38792996", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/medicina60050811" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Acides aminés", "item": "https://questionsmedicales.fr/mesh/D000596" }, { "@type": "ListItem", "position": 4, "name": "Acides aminés soufrés", "item": "https://questionsmedicales.fr/mesh/D000603" }, { "@type": "ListItem", "position": 5, "name": "Cystéine", "item": "https://questionsmedicales.fr/mesh/D003545" }, { "@type": "ListItem", "position": 6, "name": "Acétylcystéine", "item": "https://questionsmedicales.fr/mesh/D000111" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Acétylcystéine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Acétylcystéine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Acétylcystéine", "description": "Comment l'acétylcystéine est-elle utilisée dans le diagnostic ?\nQuels tests peuvent nécessiter l'acétylcystéine ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Acétylcystéine", "description": "Quels symptômes l'acétylcystéine aide-t-elle à soulager ?\nQuels effets secondaires peuvent survenir ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Acétylcystéine", "description": "L'acétylcystéine peut-elle prévenir des complications ?\nComment l'acétylcystéine aide-t-elle en prévention ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Acétylcystéine", "description": "Dans quels cas l'acétylcystéine est-elle prescrite ?\nComment l'acétylcystéine est-elle administrée ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Acétylcystéine", "description": "Quelles complications peuvent survenir avec l'acétylcystéine ?\nL'acétylcystéine peut-elle interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Acétylcystéine", "description": "Qui devrait éviter l'acétylcystéine ?\nQuels facteurs augmentent le risque d'effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment l'acétylcystéine est-elle utilisée dans le diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle aide à évaluer la fonction pulmonaire en fluidifiant les sécrétions bronchiques." } }, { "@type": "Question", "name": "Quels tests peuvent nécessiter l'acétylcystéine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire peuvent être réalisés pour évaluer l'efficacité du traitement." } }, { "@type": "Question", "name": "Quels symptômes l'acétylcystéine aide-t-elle à soulager ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elle soulage la toux et les difficultés respiratoires dues à des sécrétions épaisses." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent survenir ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des nausées, vomissements ou éruptions cutanées peuvent se produire chez certains patients." } }, { "@type": "Question", "name": "L'acétylcystéine peut-elle prévenir des complications ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut prévenir des lésions hépatiques en cas d'intoxication au paracétamol." } }, { "@type": "Question", "name": "Comment l'acétylcystéine aide-t-elle en prévention ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Elle réduit la viscosité des sécrétions, facilitant leur élimination et prévenant les infections." } }, { "@type": "Question", "name": "Dans quels cas l'acétylcystéine est-elle prescrite ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle est prescrite pour traiter les maladies respiratoires et les overdoses de paracétamol." } }, { "@type": "Question", "name": "Comment l'acétylcystéine est-elle administrée ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être administrée par voie orale ou intraveineuse, selon la situation clinique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'acétylcystéine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques graves, bien que rares, peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "L'acétylcystéine peut-elle interagir avec d'autres médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut interagir avec certains antibiotiques et médicaments anticoagulants." } }, { "@type": "Question", "name": "Qui devrait éviter l'acétylcystéine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques à l'acétylcystéine ou ayant des antécédents d'asthme sévère." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'effets secondaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'allergies et les maladies respiratoires chroniques peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Functional Recovery During Inpatient Rehabilitation in Children With Anoxic or Hypoxic Brain Injury.

To (1) describe characteristics of children with anoxic or hypoxic brain injuries (AnHBI) who presented to an inpatient rehabilitation unit, (2) explore functional outcomes of children with AnHBI at d... Retrospective cohort study.... Pediatric inpatient rehabilitation hospital in the Northeast United States.... A total of 46 children and adolescents ages 11 months to 18 years admitted to an inpatient rehabilitation brain injury unit (1994-2018) for a first inpatient admission after AnHBI.... Not applicable.... Pediatric Cerebral Performance Category Scale (PCPC), Pediatric Overall Performance Category, and Functional Independence Measure for Children developmental functional quotients (WeeFIM DFQs) total an... Most children had no disability before injury (PCPC=normal, n=37/46) and displayed significant functional impairments at admission to inpatient rehabilitation (PCPC=normal/mild, n=1/46). WeeFIM and PC... In this group of children with AnHBI who received inpatient rehabilitation, functional status improves significantly between rehabilitation admission and discharge. By discharge, many children continu...

Impact of intravenous dexmedetomidine on postoperative gastrointestinal function recovery: an updated meta-analysis.

Postoperative ileus (POI) is a complication that may occur after abdominal or nonabdominal surgery. Intravenous dexmedetomidine (Dex) has been reported to accelerate postoperative gastrointestinal fun... To identify randomized controlled trials examining the effects of perioperative intravenous Dex on gastrointestinal function recovery in patients undergoing noncardiac surgery, databases including MED... The meta-analysis of 22 randomized controlled trials with 2566 patients showed that Dex significantly reduced the time to flatus [mean difference (MD):-7.19 h, P <0.00001), time to oral intake (MD: -6... Perioperative intravenous Dex may enhance postoperative gastrointestinal function recovery and reduce LOS, thereby validating its use in patients for whom postoperative ileus is a significant concern....

Factors associated with failure of cardiopulmonary function recovery after lung cancer surgery.

This study aimed to evaluate the longitudinal changes in cardiopulmonary function (CPF) and identify predictors of cardiopulmonary recovery failure after lung cancer surgery.... Data was obtained from a prospective CATCH-LUNG cohort study, where patients were divided into two groups based on 6-min walk distance (6MWD) at baseline and 6 months after surgery. CPF recovery failu... Among 419 patients, 24.1% and 17.7% showed failure of CPF recovery at 6 months and 1 year after surgery, respectively. In the multivariable analysis, baseline step count [RR per 1000 steps lower = 1.0... The inability to recover CPF at 6 months after surgery was linked to reduction of lung function and MVPA from baseline to 2 weeks as well as baseline physical activity (PA) and dyspnoea. These results...

Cross-validation of predictive models for functional recovery after post-stroke rehabilitation.

Rehabilitation treatments and services are essential for the recovery of post-stroke patients' functions; however, the increasing number of available therapies and the lack of consensus among outcome ... A dataset of 278 post-stroke patients was used for the prediction of the class transition, obtained from the modified Barthel Index. Four classification algorithms were cross-validated and compared. O... The Random Forest obtained the best overall results on the accuracy (76.2%), balanced accuracy (74.3%), sensitivity (0.80), and specificity (0.68). The combination of all the classification results on... Despite a more comprehensive assessment of the patients is needed, this work paves the way for the implementation of solutions for clinical decision support in the rehabilitation of post-stroke patien...

Retinal Damage and Visual Network Reconfiguration Defines Visual Function Recovery in Optic Neuritis.

Recovery of vision after acute optic neuritis (AON) is critical to improving the quality of life of people with demyelinating diseases. The objective of the study was to prospectively assess the chang... We studied a prospective cohort of 88 consecutive patients with AON with 6-month follow-up using high and low-contrast (2.5%) visual acuity, color vision, retinal thickness from optical coherence tomo... We found that after 6 months, low-contrast vision and quality of vision remained moderately impaired. The thickness of the ganglion cell layer at baseline was a predictor of low-contrast vision 6 mont... The assessment of the visual pathway at baseline predicts permanent vision disability after AON, indicating that damage is produced early after disease onset and that it can be used for defining visio...

Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.

Oral corticosteroid (OCS) dependence among patients with severe eosinophilic asthma can cause adverse outcomes, including adrenal insufficiency. PONENTE's OCS reduction phase showed that, following be... The maintenance phase assessed the durability of corticosteroid reduction and further adrenal function recovery. For ∼6 months, patients continued benralizumab 30 mg every 8 weeks without corticostero... 598 patients entered PONENTE; 563 (94.1%) completed the reduction phase and entered the maintenance phase. From the end of reduction to the end of maintenance, the median (range) OCS dosage was unchan... Most patients successfully maintained maximal OCS reduction while achieving improved asthma control with few exacerbations and maintaining or recovering adrenal function....

Changes of cortico-cortical neural connections associated with motor functional recovery after stroke.

During functional recovery after stroke, some neural connections in the brain are augmented and new neural networks are constructed to compensate for impaired neurological functions. Recently, it was ... Twenty-two post-stroke hemiparetic patients admitted to our rehabilitation ward (mean age at admission: 71.4 ± 12.9 years old), were studied. For the evaluation of hemiparesis, Fugl-Meyer Assessment (... The correlation coefficients in some cortico-cortical areas of the lesional hemisphere, such as C3-F3 or C4-F4, C3-F7 or C4-F8, and F3-F7 or F4-F8, significantly increased with rehabilitation training... The augmentation of cortico-cortical connections, represented by an increase of the correlation coefficient in the lesional hemisphere, may contribute to motor functional recovery, especially in hemip...

Prediction model of renal function recovery for primary membranous nephropathy with acute kidney injury.

The clinical and pathological impact factors for renal function recovery in acute kidney injury (AKI) on the progression of renal function in primary membranous nephropathy (PMN) with AKI patients hav... Two PMN with AKI cohorts from the Nephrology Department, the First Affiliated Hospital of Wenzhou Medical University during 2012-2018 and 2019-2020 were included, i.e., a derivation cohort during 2012... Renal function recovery was found in 72 of 124 (58.1%) patients and 41 of 72 (56.9%) patients in the derivation and validation cohorts, respectively. The prognostic nomogram model included determinant... The predictive nomogram model provides useful prognostic tool for renal function recovery in PMN patients with AKI....

Comparison of Functional Recovery Between Unicompartmental and Total Knee Arthroplasty: A Randomized Controlled Trial.

Comparisons of functional recovery between unicompartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA) using performance-based tests are lacking. Therefore, this study aimed to compare ... We conducted a randomized controlled trial comparing medial UKA and TKA in patients with isolated medial knee OA. A total of 110 patients were enrolled; after 11 exclusions, 99 patients (50 UKA, 49 TK... The mean 2MWT distance after UKA was significantly longer than that after TKA at 6 weeks (96.5 ± 22.6 m for UKA compared with 81.1 ± 19.1 m for TKA; difference, 18 m [95% confidence interval (CI),10.4... The 2MWT indicated that UKA for isolated medial knee OA enabled faster recovery than TKA did at 6 weeks to 6 months, and earlier recovery was also seen with the TUG at 6 weeks to 3 months. The 2MWT an... Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence....